Caroline Chloe Simmons, | |
1612 Hamric Dr E Ste 102, Oxford, AL 36203-8057 | |
(256) 624-6377 | |
Not Available |
Full Name | Caroline Chloe Simmons |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1612 Hamric Dr E Ste 102, Oxford, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619665296 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 5353 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Caroline Chloe Simmons, 1612 Hamric Dr E Ste 102, Oxford, AL 36203-8057 Ph: () - | Caroline Chloe Simmons, 1612 Hamric Dr E Ste 102, Oxford, AL 36203-8057 Ph: (256) 624-6377 |
News Archive
Meanwhile, the Obama administration announced it would add new funds to increase access to HIV/AIDS care, but questions remain about whether it will be enough to address waiting lists for the drug assistance program. Also in the news, reports on treatment developments.
Obesity gene testing does not put people off weight loss and may help to reduce self-blame, according to a new study by researchers from the Health Behaviour Research Centre at UCL (University College London).
High-throughput analysis of blood plasma could aid in identification of diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis (ALS), according to research from North Carolina State University.
Years of research have shown that impulsivity in childhood is among the individual vulnerabilities leading to substance abuse, delinquency, as well as aggressive and antisocial behavior in adolescence and adulthood.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 1b study designed to evaluate the safety of MP4CO treatment in patients with sickle cell disease.
› Verified 6 days ago
Mrs. Gwen Lee Moore, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1130 Hale St, Oxford, AL 36203 Phone: 256-831-0481 | |
Mrs. Betsy Brittain Brittain, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1130 South Hale Street, Oxford, AL 36203 Phone: 256-831-0481 | |
Ms. Kristi K Mccormick, MS, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 320 Snow St, Oxford, AL 36203 Phone: 256-770-5009 | |
Ashley Holland, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1612 Hamric Dr E Ste 102, Oxford, AL 36203 Phone: 256-624-6377 |